NZ222544A - Rebeccamycin analogues and their preparation; pharmaceutical compositions thereof - Google Patents

Rebeccamycin analogues and their preparation; pharmaceutical compositions thereof

Info

Publication number
NZ222544A
NZ222544A NZ222544A NZ22254487A NZ222544A NZ 222544 A NZ222544 A NZ 222544A NZ 222544 A NZ222544 A NZ 222544A NZ 22254487 A NZ22254487 A NZ 22254487A NZ 222544 A NZ222544 A NZ 222544A
Authority
NZ
New Zealand
Prior art keywords
alkyl
rebeccamycin
alkoxycarbonyl
mono
alkoxy
Prior art date
Application number
NZ222544A
Other languages
English (en)
Inventor
Takushi Kaneko
Henry S Wong
Jacob J Utzig
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ222544A publication Critical patent/NZ222544A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
NZ222544A 1986-11-21 1987-11-13 Rebeccamycin analogues and their preparation; pharmaceutical compositions thereof NZ222544A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/933,428 US4785085A (en) 1986-11-21 1986-11-21 Rebeccamycin analogs

Publications (1)

Publication Number Publication Date
NZ222544A true NZ222544A (en) 1990-11-27

Family

ID=25463937

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ222544A NZ222544A (en) 1986-11-21 1987-11-13 Rebeccamycin analogues and their preparation; pharmaceutical compositions thereof

Country Status (28)

Country Link
US (1) US4785085A (https=)
EP (1) EP0269025B1 (https=)
JP (1) JPS63198695A (https=)
KR (1) KR910000897B1 (https=)
CN (1) CN1019806B (https=)
AT (1) ATE84539T1 (https=)
AU (1) AU614068B2 (https=)
CA (1) CA1287349C (https=)
CS (1) CS265248B2 (https=)
CY (1) CY1701A (https=)
DE (1) DE3783577T2 (https=)
DK (1) DK165986C (https=)
EG (1) EG18409A (https=)
ES (1) ES2053510T3 (https=)
FI (1) FI86189C (https=)
GR (1) GR3006776T3 (https=)
HK (1) HK49093A (https=)
HU (1) HU201773B (https=)
IE (1) IE60595B1 (https=)
IL (1) IL84515A (https=)
MX (1) MX9202849A (https=)
MY (1) MY102722A (https=)
NO (1) NO167741C (https=)
NZ (1) NZ222544A (https=)
PT (1) PT86188B (https=)
SG (1) SG25193G (https=)
YU (1) YU46087B (https=)
ZA (1) ZA878714B (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
JPH0725787B2 (ja) * 1990-03-06 1995-03-22 ブリストル−マイヤーズ スクイブ カンパニー 臭化物前駆物質物質供給によるレベカマイシン類似体
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
EP0528030B1 (en) * 1990-05-11 1997-09-17 Banyu Pharmaceutical Co., Ltd. Antitumor be-13793c derivative
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5547976A (en) * 1992-03-20 1996-08-20 Burroughs Wellcome Co. Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
PT657458E (pt) * 1993-12-07 2002-02-28 Lilly Co Eli Inibidores de proteina cinase c
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
EP0657411B1 (en) * 1993-12-07 1999-06-09 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
CA2179650C (en) * 1993-12-23 2007-10-30 William Francis Heath, Jr. Bisindolemaleimides and their use as protein kinase c inhibitors
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
DE69531686T2 (de) * 1994-06-13 2004-07-15 Banyu Pharmaceutical Co., Ltd. Glycosyltransferase kodierendes gen und seine verwendung
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
EP0695755B1 (en) * 1994-08-04 1998-10-21 F. Hoffmann-La Roche AG Pyrrolocarbazole
WO1997009339A1 (fr) * 1995-09-05 1997-03-13 Banyu Pharmaceutical Co., Ltd. Derives antitumoraux d'indolopyrrolocarbazole
US5919946A (en) * 1996-03-20 1999-07-06 Eli Lilly And Company Synthesis of indolylmaleimides
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
RU2003131269A (ru) 2001-03-22 2005-05-10 Бристол-Маерс Сквибб Компани (Us) Производные индолопирролокарбазолов и сахаров, цитотоксические и селективные по отношению к топоизомеразе i
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
US20070042975A1 (en) * 2003-09-16 2007-02-22 Koji Yamada Novel indolopyrrolocarbazole derivative with antitumor activity
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102125578B (zh) * 2010-11-24 2013-03-27 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法
CN102898489B (zh) * 2010-11-24 2014-04-02 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１

Also Published As

Publication number Publication date
YU208687A (en) 1988-10-31
AU8114887A (en) 1988-05-26
KR910000897B1 (ko) 1991-02-12
DK612987D0 (da) 1987-11-20
PT86188B (pt) 1990-11-07
FI86189C (fi) 1992-07-27
IE873152L (en) 1988-05-21
CN87107928A (zh) 1988-08-10
ES2053510T3 (es) 1994-08-01
PT86188A (en) 1987-12-01
FI875091A7 (fi) 1988-05-22
YU46087B (sh) 1992-12-21
IL84515A (en) 1991-11-21
CA1287349C (en) 1991-08-06
IE60595B1 (en) 1994-07-27
CS265248B2 (en) 1989-10-13
CY1701A (en) 1994-01-14
SG25193G (en) 1993-05-21
NO167741B (no) 1991-08-26
NO874857L (no) 1988-05-24
EP0269025A2 (en) 1988-06-01
DE3783577D1 (de) 1993-02-25
MX9202849A (es) 1992-06-30
HUT45543A (en) 1988-07-28
JPS63198695A (ja) 1988-08-17
FI86189B (fi) 1992-04-15
NO874857D0 (no) 1987-11-20
ATE84539T1 (de) 1993-01-15
DK165986C (da) 1993-07-19
NO167741C (no) 1991-12-04
EP0269025A3 (en) 1990-08-29
ZA878714B (https=) 1988-05-20
FI875091A0 (fi) 1987-11-18
KR880006246A (ko) 1988-07-22
DK612987A (da) 1988-05-22
MY102722A (en) 1992-09-30
AU614068B2 (en) 1991-08-22
HK49093A (en) 1993-05-27
US4785085A (en) 1988-11-15
EG18409A (en) 1993-02-28
DK165986B (da) 1993-02-22
GR3006776T3 (https=) 1993-06-30
HU201773B (en) 1990-12-28
JPH05400B2 (https=) 1993-01-05
DE3783577T2 (de) 1993-05-19
EP0269025B1 (en) 1993-01-13
IL84515A0 (en) 1988-04-29
CN1019806B (zh) 1992-12-30
CS824987A2 (en) 1989-01-12

Similar Documents

Publication Publication Date Title
EP0269025B1 (en) Rebeccamycin analogs
US4808613A (en) Rebeccamycin derivative containing pharmaceutical composition
EP0406749B1 (en) DC-88A derivatives
Peterson et al. Synthesis and biological evaluation of 4-purinylpyrrolidine nucleosides
US4579854A (en) Bronchodilating 8-hydroxy-5-{(1R)-1-hydroxy-2-[N-((1R)-2-(p-methoxyphenyl)-1-methylethyl)-amino]ethyl} carbostyril
US4071680A (en) 5'-Deoxy-5-fluoropyrimidine nucleosides
US3931401A (en) 1,N6 -etheno-5'-adenosine carboxamides for increasing coronary sinus partial pressure of oxygen
GB2066812A (en) 5'-acyl-uridine derivatives and processes for the preparation thereof
US5532218A (en) 3'-aziridino-anthracycline derivatives
GB1599928A (en) Process for producing glycopyranosenitrosourea compounds and a compound included therein
JP4621588B2 (ja) 新規化合物カプラゼンとカプラゼン誘導体、ならびに新規化合物カプラゾールとカプラゾール誘導体
RU2065863C1 (ru) Производные дезацетилколхицина, способ их получения и противоопухолевая композиция
NZ205669A (en) Anthracycline glycosides,intermediates,and pharmaceutical compositions
EP0760375B1 (en) Antitumor indolopyprolocarbazole derivative
US4946957A (en) Anti-tumor DC-52 derivatives
EP0456514B1 (en) 2-Fluoroneplanocin A and its production
US3852268A (en) Inosine-5 -carboxylic acid amides
EP0601520A1 (en) Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same
HK1011692B (en) 3'-aziridino-anthracycline derivatives
JPH0834788A (ja) ピロロベンゾカルバゾール誘導体及びその製造方法
JPH06116267A (ja) ６’−ｃ−アルキルもしくはアルキニルネプラノシンａ、その製造方法およびその用途
HK1000707A (en) Dc-88a derivatives
JPH08283271A (ja) インドロカルバゾール誘導体
PL155212B1 (en) Method of obtaining novel derivatives or ribofuranuronic acid